ArticleOncogene2018
FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
Yan-Hong Cui et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it
ArticleOncogene2018
Yan-Hong Cui et al.PubMed ↗Publisher ↗
No numbers read from the abstract.